BioSpace News Archive

Drug Development

Positive Results Announced from Phase 3 OCARINA II Trial Evaluating Roche’s OCREVUS® (ocrelizumab) with Halozyme’s ENHANZE® Drug Delivery Technology in Patients with Multiple Sclerosis

Halozyme Therapeutics, Inc. announced that Roche’s Phase 3 OCARINA II trial evaluating OCREVUS® with ENHANZE® as a twice a year 10-minute subcutaneous injection, met its primary and secondary endpoints in patients with relapsing forms of multiple sclerosis or primary progressive MS.

July 13, 2023
·
5 min read
EG 427 announces final Series A closing, achieving €18 million in total funds raised

EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions, announces the final closing of a Series A financing.

July 13, 2023
·
4 min read
Business

Pluri Announces Appointment of Entrepreneur Lorne Abony to Board of Directors

Pluri Inc., a leading biotech company that transforms cells into solutions that promote wellbeing and sustainability, announced the appointment of Lorne Abony to the Company’s Board of Directors, effective as of July 11, 2023.

July 13, 2023
·
5 min read
Business

Pharming Group to report second quarter and first half 2023 financial results on August 3

Pharming Group N.V. confirms it will report its preliminary second quarter and first half 2023 financial results, for the period ended June 30, on Thursday, August 3, 2023.

July 13, 2023
·
1 min read
Business

XVIVO Presents Interim Report January-June 2023

Net sales amounted to SEK 154.6 million, corresponding to an increase of 64 percent in SEK and 52 percent in local currencies.

July 13, 2023
·
5 min read
Drug Development

Calliditas announces supportive interim data from Phase 2 head and neck cancer trial with lead NOX inhibitor candidate, setanaxib

Calliditas Therapeutics AB announced interim data from the proof-of-concept Phase 2 trial in patients with squamous cell carcinoma of the head and neck with its lead NOX 1 and 4 inhibitor product candidate, setanaxib.

July 13, 2023
·
6 min read
Discovery Of New Genetic Biomarkers May Pave The Way For A Lab Test For Bipolar Spectrum Disorder Within Three Years

A research team from The London Psychiatry Centre has discovered new genetic biomarkers in bipolar spectrum disorder.

July 13, 2023
·
2 min read
Business

HUTCHMED Announces Changes to Board of Directors and Technical Committee Ms Ling Yang to replace Mr Lefei Sun as Non-executive Director; Professor Solange Peters appointed as Special Advisor to the Technical Committee

HUTCHMED Limited announces that with effect from July 13, 2023:

July 13, 2023
·
6 min read
Novotech Announced as Finalist for Asia Pacific Cell & Gene Therapy CRO Excellence Awards 2023

Novotech, the leading Asia Pacific centred biotech CRO with global execution capabilities is a finalist in the Asia Pacific Cell & Gene Therapy Awards 2023.

July 13, 2023
·
3 min read
Opthea to Feature at the American Society of Retina Specialists 2023 Annual Meeting

Opthea Limited announced that OPT-302, the Company’s first-in-class VEGF-C/D “trap” inhibitor will be highlighted during the upcoming American Society of Retina Specialists 2023 Annual Meeting in Seattle, Washington.

July 13, 2023
·
4 min read